Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US. Jara M, Barker G, Henney HR Neuropsychiatr Dis Treat. 2013; 9:365-70. Epub 2013 Mar 10. PMID: 23662056. Abstract CommentRecommendBookmarkWatch